<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Enliven Therapeutics, Inc. (ELVN) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/elvn/filings</link>
    <description>Latest company filings for Enliven Therapeutics, Inc. (ELVN) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Fri, 10 Jul 2026 00:03:42 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/elvn/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000170124726000007/xslF345X06/form4-05202026_080544.xml</link>
      <guid isPermaLink="false">0001701247-26-000007</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-05-20.]]></description>
      <pubDate>Wed, 20 May 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000197415826000069/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974158-26-000069</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000183194226000024/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001831942-26-000024</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ELVN: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000173804826000062/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001738048-26-000062</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ELVN: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000117266126002402/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001172661-26-002402</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ELVN: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000117266126002051/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001172661-26-002051</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ELVN: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000110465926062642/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-062642</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ELVN: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000090266426002551/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000902664-26-002551</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000119312526211982/elvn-20260331.htm</link>
      <guid isPermaLink="false">0001193125-26-211982</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Quarterly report (10-Q) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000119312526211921/elvn-20260507.htm</link>
      <guid isPermaLink="false">0001193125-26-211921</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Major company event (8-K) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000197415826000062/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974158-26-000062</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000119312526182102/d948538dars.pdf</link>
      <guid isPermaLink="false">0001193125-26-182102</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Annual report to shareholders (ARS) on 2026-04-27.]]></description>
      <pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000119312526182081/d948532ddefa14a.htm</link>
      <guid isPermaLink="false">0001193125-26-182081</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-04-27.]]></description>
      <pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000119312526182045/d948512ddef14a.htm</link>
      <guid isPermaLink="false">0001193125-26-182045</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Proxy statement (DEF 14A) on 2026-04-27.]]></description>
      <pubDate>Mon, 27 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000170124726000006/xslF345X06/form4-04222026_120411.xml</link>
      <guid isPermaLink="false">0001701247-26-000006</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-04-21.]]></description>
      <pubDate>Tue, 21 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: PRE 14A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000119312526156995/d948512dpre14a.htm</link>
      <guid isPermaLink="false">0001193125-26-156995</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a PRE 14A (PRE 14A) on 2026-04-15.]]></description>
      <pubDate>Wed, 15 Apr 2026 12:00:00 GMT</pubDate>
      <category>PRE 14A</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000197415826000031/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974158-26-000031</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-31.]]></description>
      <pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000195004726003102/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-003102</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-31.]]></description>
      <pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000170124726000005/xslF345X06/form4-03272026_080317.xml</link>
      <guid isPermaLink="false">0001701247-26-000005</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-03-27.]]></description>
      <pubDate>Fri, 27 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000197415826000026/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974158-26-000026</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-25.]]></description>
      <pubDate>Wed, 25 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000197415826000025/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974158-26-000025</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-24.]]></description>
      <pubDate>Tue, 24 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000170124726000004/xslF345X06/form4-03192026_090347.xml</link>
      <guid isPermaLink="false">0001701247-26-000004</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-03-19.]]></description>
      <pubDate>Thu, 19 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000170124726000003/xslF345X05/form4-03112026_090319.xml</link>
      <guid isPermaLink="false">0001701247-26-000003</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-03-11.]]></description>
      <pubDate>Wed, 11 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000188276426000002/xslF345X05/form4-03102026_100318.xml</link>
      <guid isPermaLink="false">0001882764-26-000002</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-03-10.]]></description>
      <pubDate>Tue, 10 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000197415826000023/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974158-26-000023</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-09.]]></description>
      <pubDate>Mon, 09 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000197415826000022/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974158-26-000022</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-06.]]></description>
      <pubDate>Fri, 06 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000119312526088785/d189577ds8.htm</link>
      <guid isPermaLink="false">0001193125-26-088785</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Employee stock plan (S-8) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000119312526088232/elvn-20251231.htm</link>
      <guid isPermaLink="false">0001193125-26-088232</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Annual report (10-K) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000119312526088195/elvn-20260303.htm</link>
      <guid isPermaLink="false">0001193125-26-088195</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-03.]]></description>
      <pubDate>Tue, 03 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000170124726000002/xslF345X05/form4-02192026_110242.xml</link>
      <guid isPermaLink="false">0001701247-26-000002</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-19.]]></description>
      <pubDate>Thu, 19 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000158475926000009/xslF345X05/form4-02192026_110223.xml</link>
      <guid isPermaLink="false">0001584759-26-000009</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-19.]]></description>
      <pubDate>Thu, 19 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000197415826000020/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974158-26-000020</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-18.]]></description>
      <pubDate>Wed, 18 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000197415826000019/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974158-26-000019</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000197415826000018/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974158-26-000018</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000197415826000017/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001974158-26-000017</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000196716326000002/xslF345X05/form4-02182026_120233.xml</link>
      <guid isPermaLink="false">0001967163-26-000002</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000196715026000004/xslF345X05/form4-02182026_120203.xml</link>
      <guid isPermaLink="false">0001967150-26-000004</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000188276426000001/xslF345X05/form4-02182026_120228.xml</link>
      <guid isPermaLink="false">0001882764-26-000001</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000186512526000001/xslF345X05/form4-02182026_120255.xml</link>
      <guid isPermaLink="false">0001865125-26-000001</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000180509726000001/xslF345X05/form4-02182026_120215.xml</link>
      <guid isPermaLink="false">0001805097-26-000001</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000170124726000001/xslF345X05/form4-02182026_120250.xml</link>
      <guid isPermaLink="false">0001701247-26-000001</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000165490926000001/xslF345X05/form4-02182026_120203.xml</link>
      <guid isPermaLink="false">0001654909-26-000001</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000158475926000008/xslF345X05/form4-02182026_010204.xml</link>
      <guid isPermaLink="false">0001584759-26-000008</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000153737026000001/xslF345X05/form4-02182026_120208.xml</link>
      <guid isPermaLink="false">0001537370-26-000001</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000153636826000003/xslF345X05/form4-02182026_010205.xml</link>
      <guid isPermaLink="false">0001536368-26-000003</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000153322826000003/xslF345X05/form4-02182026_120252.xml</link>
      <guid isPermaLink="false">0001533228-26-000003</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000090266426001079/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000902664-26-001079</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000196715026000003/xslF345X05/form4-02102026_110257.xml</link>
      <guid isPermaLink="false">0001967150-26-000003</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-02-10.]]></description>
      <pubDate>Tue, 10 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000195004726000852/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000852</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ELVN: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1672619/000196715026000002/xslF345X05/form4-01222026_100144.xml</link>
      <guid isPermaLink="false">0001967150-26-000002</guid>
      <description><![CDATA[Enliven Therapeutics, Inc. filed a Insider trade (4) on 2026-01-22.]]></description>
      <pubDate>Thu, 22 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
  </channel>
</rss>